- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVAX
Recent news which mentions NVAX
Why Is Novavax (NVAX) Stock Falling Today?
September 22, 2022
From InvestorPlace
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket
September 22, 2022
From Benzinga
US Stock Futures Rise Following Wednesday's Plunge
September 22, 2022
From Benzinga
Nikola, Super Micro Computer And Other Big Losers From Monday
September 20, 2022
From Benzinga
Vaccine Stocks: Down but Not Out?
September 19, 2022
From Motley Fool
Why Novavax and Johnson & Johnson Stocks Slipped Today
September 19, 2022
From Motley Fool
Why Moderna Stock Dropped Today
September 19, 2022
From Motley Fool
Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today?
September 19, 2022
From InvestorPlace
Health experts dismayed by President Biden’s view that the pandemic is over: ‘Hell no — not even close’
September 19, 2022
From MarketWatch
Why BioNTech, Moderna And Novavax Shares Are Diving
September 19, 2022
From Benzinga
Europe may give COVID vaccines full marketing authorization to avoid annual review, and WHO backs Gilead’s Veklury for severe disease
September 16, 2022
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2022
From Benzinga
These 20 stocks have short interest of 19% or more, and AMC and GameStop are not even in the top half
September 15, 2022
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
September 13, 2022
From Benzinga
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
From Benzinga
Europe Approves Novavax's COVID-19 Vaccine Booster For Adults
September 12, 2022
Tickers
NVAX
From Benzinga
3 Stocks Expecting Good News From the FDA
September 12, 2022
From Motley Fool
Here's Why These Top 3 COVID-19 Vaccine Stocks Broke Down in August
September 08, 2022
From Motley Fool
Nasdaq Bear Market: 3 Growth Stocks That Crashed Over 30% in August
September 08, 2022
From Motley Fool
Should You Buy the Nasdaq's 10 Worst-Performing 2022 Stocks?
September 08, 2022
From Motley Fool
Stocks That Hit 52-Week Lows On Wednesday
September 07, 2022
From Benzinga
Why Novavax Stock Sank to a New 52-Week Low Today
September 06, 2022
From Motley Fool
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
September 02, 2022
From Benzinga
COVID boosters that target dominant omicron strains set to start in coming days after CDC gives its OK
September 02, 2022
From MarketWatch
1 Growth Stock That's Played Out and 1 That's Just Starting
September 02, 2022
From Motley Fool
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
From Benzinga
What Is Going on With Vaxart (VXRT) Stock Today?
September 01, 2022
From InvestorPlace
Europe Backs Approval Of Omicron-Adapted COVID-19 Vaccines
September 01, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.